• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

某些锌配合物与氯喹和羟氯喹对新型冠状病毒肺炎主要蛋白酶疗效的分子对接鉴定

Molecular docking identification for the efficacy of some zinc complexes with chloroquine and hydroxychloroquine against main protease of COVID-19.

作者信息

Hussein R K, Elkhair H M

机构信息

Imam Mohammad Ibn Saud Islamic University (IMSIU), College of Science, Physics department, P.O. Box 90950, Riyadh 11623, Saudi Arabia.

Department of Physics, Al Neelain University, P. O. Box 12702, Khartoum 11121, Sudan.

出版信息

J Mol Struct. 2021 May 5;1231:129979. doi: 10.1016/j.molstruc.2021.129979. Epub 2021 Jan 25.

DOI:10.1016/j.molstruc.2021.129979
PMID:33518801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7830318/
Abstract

Vast amount of research has been recently conducted to discover drugs for efficacious treatment of corona virus disease 2019 (COVID-19). The ambiguity about using Chloroquine/ Hydroxychloroquine to treat this illness was a springboard towards new methods for improving the adequacy of these drugs. The effective treatment of COVID-19 using Zinc complexes as add-on to Chloroquine/ Hydroxychloroquine has received major attention in this context. The current studies have shed a light on molecular docking and molecular dynamics methodologies as powerful techniques in establishing therapeutic strategies to combat COVID-19 pandemic. We are proposing some zinc compounds coordination to Chloroquine/ Hydroxychloroquine in order to enhance their activity. The molecular docking calculations showed that Zn(QC)Cl2(H2O) has the least binding energy -7.70 Kcal /mol then Zn(HQC)Cl2(H2O) -7.54 Kcal /mol. The recorded hydrogen bonds were recognized in the strongest range of H Bond category distances. Identification of binding site interactions revealed that the interaction of Zn(QC)Cl2(H2O)with the protease of COVID-19 results in three hydrogen bonds, while Zn(HQC)Cl2(H2O) exhibited a strong binding to the main protease receptor by forming eight hydrogen bonds. The dynamic behavior of the proposed complexes was revealed by molecular dynamics simulations. The outcomes obtained from Molecular dynamics calculations approved the stability of Mpro-Zn(CQ/HCQ)Cl2H2O systems. These findings recommend Zn (CQ) Cl2H2O and Zn (HCQ) Cl2H2O as potential inhibitors for COVID-19 Mpro.

摘要

最近进行了大量研究以发现有效治疗2019冠状病毒病(COVID-19)的药物。关于使用氯喹/羟氯喹治疗该疾病的不确定性成为了改进这些药物有效性新方法的跳板。在这种背景下,将锌配合物作为氯喹/羟氯喹的附加剂用于有效治疗COVID-19受到了主要关注。当前的研究揭示了分子对接和分子动力学方法是建立对抗COVID-19大流行治疗策略的有力技术。我们提出一些锌化合物与氯喹/羟氯喹配位以增强其活性。分子对接计算表明,Zn(QC)Cl2(H2O)的结合能最低,为-7.70千卡/摩尔,其次是Zn(HQC)Cl2(H2O),为-7.54千卡/摩尔。记录的氢键在氢键类别距离的最强范围内被识别。结合位点相互作用的鉴定表明,Zn(QC)Cl2(H2O)与COVID-19蛋白酶的相互作用产生三个氢键,而Zn(HQC)Cl2(H2O)通过形成八个氢键与主要蛋白酶受体表现出强结合。分子动力学模拟揭示了所提出配合物的动态行为。分子动力学计算得到的结果证实了Mpro-Zn(CQ/HCQ)Cl2H2O系统的稳定性。这些发现推荐Zn (CQ) Cl2H2O和Zn (HCQ) Cl2H2O作为COVID-19 Mpro的潜在抑制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b704/7830318/095e37a6935b/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b704/7830318/8f240d37c626/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b704/7830318/1c6c3b72c99d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b704/7830318/2e0bd6b41a77/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b704/7830318/c1caac826ce9/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b704/7830318/da6a4ebc993e/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b704/7830318/5ba8345ee297/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b704/7830318/095e37a6935b/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b704/7830318/8f240d37c626/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b704/7830318/1c6c3b72c99d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b704/7830318/2e0bd6b41a77/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b704/7830318/c1caac826ce9/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b704/7830318/da6a4ebc993e/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b704/7830318/5ba8345ee297/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b704/7830318/095e37a6935b/gr6_lrg.jpg

相似文献

1
Molecular docking identification for the efficacy of some zinc complexes with chloroquine and hydroxychloroquine against main protease of COVID-19.某些锌配合物与氯喹和羟氯喹对新型冠状病毒肺炎主要蛋白酶疗效的分子对接鉴定
J Mol Struct. 2021 May 5;1231:129979. doi: 10.1016/j.molstruc.2021.129979. Epub 2021 Jan 25.
2
Encapsulated hydroxychloroquine and chloroquine into cyclic oligosaccharides are the potential therapeutics for COVID-19: insights from first-principles calculations.将羟氯喹和氯喹包裹于环状低聚糖中是治疗新冠肺炎的潜在疗法:基于第一性原理计算的见解
J Mol Struct. 2022 Jan 5;1247:131371. doi: 10.1016/j.molstruc.2021.131371. Epub 2021 Aug 26.
3
Repurposing drugs and identification of inhibitors of integral proteins (spike protein and main protease) of SARS-CoV-2.重新利用药物和鉴定 SARS-CoV-2 的整合蛋白(刺突蛋白和主蛋白酶)抑制剂。
J Biomol Struct Dyn. 2022 Sep;40(14):6587-6602. doi: 10.1080/07391102.2021.1886993. Epub 2021 Feb 16.
4
Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?补锌能否增强氯喹/羟氯喹的临床疗效,赢得抗击 COVID-19 的今天?
Med Hypotheses. 2020 Sep;142:109815. doi: 10.1016/j.mehy.2020.109815. Epub 2020 May 6.
5
Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.氯喹和羟氯喹治疗 COVID-19:一个永无止境的故事。
Appl Microbiol Biotechnol. 2021 Feb;105(4):1333-1343. doi: 10.1007/s00253-021-11094-4. Epub 2021 Jan 30.
6
Interactions Between Remdesivir, Ribavirin, Favipiravir, Galidesivir, Hydroxychloroquine and Chloroquine with Fragment Molecular of the COVID-19 Main Protease with Inhibitor N3 Complex (PDB ID:6LU7) Using Molecular Docking.使用分子对接技术研究瑞德西韦、利巴韦林、法匹拉韦、加利地韦、羟氯喹和氯喹与新冠病毒主要蛋白酶与抑制剂N3复合物(PDB ID:6LU7)的片段分子之间的相互作用。
J Nanosci Nanotechnol. 2020 Dec 1;20(12):7311-7323. doi: 10.1166/jnn.2020.18955.
7
COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.新型冠状病毒肺炎疫情:氯喹和羟氯喹潜在作用的叙事性综述。
Pain Physician. 2020 Aug;23(4S):S351-S366.
8
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.氯喹或羟氯喹预防和治疗 COVID-19。
Cochrane Database Syst Rev. 2021 Feb 12;2(2):CD013587. doi: 10.1002/14651858.CD013587.pub2.
9
In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.计算机模拟研究阿奇霉素、氯喹和羟氯喹及其对 SARS-CoV-2 感染的潜在作用机制。
Int J Antimicrob Agents. 2020 Sep;56(3):106119. doi: 10.1016/j.ijantimicag.2020.106119. Epub 2020 Jul 30.
10
Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis.通过分子动力学模拟和氨基酸分解分析鉴定潜在的 SARS-CoV2 抑制剂。
J Biomol Struct Dyn. 2021 Oct;39(17):6633-6648. doi: 10.1080/07391102.2020.1797536. Epub 2020 Jul 24.

引用本文的文献

1
A Comprehensive Update of Anti-COVID-19 Activity of Heterocyclic Compounds.杂环化合物抗新冠病毒活性的综合更新。
Drug Des Devel Ther. 2024 May 8;18:1547-1571. doi: 10.2147/DDDT.S450499. eCollection 2024.
2
Lead Identification Through Studies: Targeting Acetylcholinesterase Enzyme Against Alzheimer's Disease.通过研究进行先导物鉴定:针对阿尔茨海默病的乙酰胆碱酯酶靶点。
Cent Nerv Syst Agents Med Chem. 2024;24(2):219-242. doi: 10.2174/0118715249268585240107184956.
3
New flavone-based arylamides as potential inhibitors: Molecular docking, DFT, and pharmacokinetic properties.

本文引用的文献

1
Zinc sulfate in combination with a zinc ionophore may improve outcomes in hospitalized COVID-19 patients.硫酸锌与锌离子载体联合应用可能改善住院 COVID-19 患者的结局。
J Med Microbiol. 2020 Oct;69(10):1228-1234. doi: 10.1099/jmm.0.001250. Epub 2020 Sep 15.
2
Inhibitory activity of hydroxychloroquine on COVID-19 main protease: An insight from MD-simulation studies.羟氯喹对新型冠状病毒主要蛋白酶的抑制活性:来自分子动力学模拟研究的见解
J Mol Struct. 2020 Nov 5;1219:128595. doi: 10.1016/j.molstruc.2020.128595. Epub 2020 Jun 2.
3
ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome.
新型黄酮基芳酰胺作为潜在抑制剂:分子对接、密度泛函理论及药代动力学性质
J Taibah Univ Med Sci. 2023 Mar 2;18(5):1000-1010. doi: 10.1016/j.jtumed.2023.02.010. eCollection 2023 Oct.
4
Exploring Scoring Function Space: Developing Computational Models for Drug Discovery.探索评分函数空间:开发药物发现的计算模型。
Curr Med Chem. 2024;31(17):2361-2377. doi: 10.2174/0929867330666230321103731.
5
Computational insight into stability-enhanced systems of anthocyanin with protein/peptide.花青素与蛋白质/肽稳定性增强系统的计算洞察
Food Chem (Oxf). 2023 Feb 21;6:100168. doi: 10.1016/j.fochms.2023.100168. eCollection 2023 Jul 30.
6
..
J Taibah Univ Med Sci. 2023 Feb 4;18(5):933-946. doi: 10.1016/j.jtumed.2023.01.013. eCollection 2023 Oct.
7
Chloroquine chaos and COVID-19: Smart delivery perspectives through pH sensitive polymers/micelles and ZnO nanoparticles.氯喹之乱与新冠肺炎:通过pH敏感聚合物/胶束和氧化锌纳米颗粒实现智能递送的前景
Arab J Chem. 2023 Feb;16(2):104468. doi: 10.1016/j.arabjc.2022.104468. Epub 2022 Nov 30.
8
Synthesis, characterization, and biological activities of zinc(II), copper(II) and nickel(II) complexes of an aminoquinoline derivative.一种氨基喹啉衍生物的锌(II)、铜(II)和镍(II)配合物的合成、表征及生物活性
Front Chem. 2022 Nov 3;10:1053532. doi: 10.3389/fchem.2022.1053532. eCollection 2022.
9
Can iron, zinc, copper and selenium status be a prognostic determinant in COVID-19 patients?铁、锌、铜和硒的状态能否成为 COVID-19 患者的预后决定因素?
Environ Toxicol Pharmacol. 2022 Oct;95:103937. doi: 10.1016/j.etap.2022.103937. Epub 2022 Jul 23.
10
Synthesis, crystal structure and studies of novel 2,4-dimethoxy-tetrahydropyrimido[4,5-]quinolin-6(7)-ones.新型2,4 - 二甲氧基 - 四氢嘧啶并[4,5 - ]喹啉 - 6(7) - 酮的合成、晶体结构及研究
RSC Adv. 2022 Jun 29;12(29):18806-18820. doi: 10.1039/d2ra02694e. eCollection 2022 Jun 22.
ACE2 受体多态性:易感性、高血压、多器官衰竭与 COVID-19 疾病结局。
J Microbiol Immunol Infect. 2020 Jun;53(3):425-435. doi: 10.1016/j.jmii.2020.04.015. Epub 2020 May 6.
4
Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?补锌能否增强氯喹/羟氯喹的临床疗效,赢得抗击 COVID-19 的今天?
Med Hypotheses. 2020 Sep;142:109815. doi: 10.1016/j.mehy.2020.109815. Epub 2020 May 6.
5
Designing of improved drugs for COVID-19: Crystal structure of SARS-CoV-2 main protease M.设计用于治疗新冠肺炎的改良药物:严重急性呼吸综合征冠状病毒2主要蛋白酶M的晶体结构
Signal Transduct Target Ther. 2020 May 9;5(1):67. doi: 10.1038/s41392-020-0178-y.
6
Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review.氯喹和羟氯喹在 COVID-19 和其他病毒感染中的治疗用途:叙述性综述。
Travel Med Infect Dis. 2020 May-Jun;35:101735. doi: 10.1016/j.tmaid.2020.101735. Epub 2020 May 6.
7
Chloroquine for COVID-19: rationale, facts, hopes.氯喹用于治疗新型冠状病毒肺炎:理论依据、事实与希望。
Crit Care. 2020 May 8;24(1):210. doi: 10.1186/s13054-020-02932-4.
8
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19.羟氯喹治疗 COVID-19 住院患者的观察性研究。
N Engl J Med. 2020 Jun 18;382(25):2411-2418. doi: 10.1056/NEJMoa2012410. Epub 2020 May 7.
9
COVID-19: Immunology and treatment options.新型冠状病毒肺炎:免疫学与治疗选择。
Clin Immunol. 2020 Jun;215:108448. doi: 10.1016/j.clim.2020.108448. Epub 2020 Apr 27.
10
Improving the efficacy of Chloroquine and Hydroxychloroquine against SARS-CoV-2 may require Zinc additives - A better synergy for future COVID-19 clinical trials.提高氯喹和羟氯喹对严重急性呼吸综合征冠状病毒2的疗效可能需要添加锌——为未来的新型冠状病毒肺炎临床试验实现更好的协同作用。
Infez Med. 2020;28(2):192-197.